<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is a precursor of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, via <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> increases substantially with <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, particularly high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, there is a clinical need to identify and treat patients with early-stage disease (<z:mpath ids='MPATH_160'>metaplasia</z:mpath> and low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) that are at high risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Activated Wnt signalling is critical for <z:mpath ids='MPATH_458'>normal</z:mpath> intestinal development and homeostasis, but less so for oesophageal development </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, we asked whether abnormally increased Wnt signalling contributes to the development of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (<z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>) and/or <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Forty patients with Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> underwent endoscopy and biopsy </plain></SENT>
<SENT sid="6" pm="."><plain>Mice with <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>- and β-naphthoflavone-induced expression of activated β-catenin were used to up-regulate Wnt signalling in mouse oesophagus </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemistry of β-catenin, Ki67, a panel of Wnt target genes, and markers of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> was performed on human and mouse tissues </plain></SENT>
<SENT sid="8" pm="."><plain>In human tissues, expression of nuclear activated β-catenin was found in <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, particularly high grade </plain></SENT>
<SENT sid="9" pm="."><plain>Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> did not show high levels of activated β-catenin </plain></SENT>
<SENT sid="10" pm="."><plain>Up-regulation of Ki67 and Wnt target genes was also mostly associated with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="11" pm="."><plain>Aberrant activation of Wnt signalling in mouse oesophagus caused marked tissue disorganization with features of <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, but only selected molecular indicators of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Based on these results in human tissues and a mouse model, we conclude that abnormal activation of Wnt signalling likely plays only a minor role in initiation of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> but a more critical role in progression to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>